Immunreconstitution and Infectious Complications After Rituximab Treatment in Children and Adolescents: What Do We Know and What Can We Learn from Adults?

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report

(2014) Stanton Goldman et al.   BRITISH JOURNAL OF HAEMATOLOGY

The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE

(2014) L Watson et al.   LUPUS

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

(2014) R. C. Dale et al.   NEUROLOGY

Evaluation of Significance of Lymphocyte Subpopulations and Non-specific Serologic Markers in B-cell Non-Hodgkin’s Lymphoma Patients

(2014) Éva Pósfai et al.   PATHOLOGY & ONCOLOGY RESEARCH

Complicated pathophysiology behind rituximab-induced persistent hypogammaglobulinemia

(2013) Gen Kano et al.   IMMUNOLOGY LETTERS

Plasma Cytokine Profiles at Diagnosis in Pediatric Patients With Non-Hodgkin Lymphoma

(2013) Karin Mellgren et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Therapy of Advanced-stage Mature B-cell Lymphoma and Leukemia in Children and Adolescents With Rituximab and Reduced Intensity Induction Chemotherapy (B-NHL 2004M Protocol)

(2013) Elena V. Samochatova et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

(2013) Josée Golay et al.   mAbs

Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies

(2012) Marcin Okroj et al.   CANCER TREATMENT REVIEWS

Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections

(2012) Carla Casulo et al.   Clinical Lymphoma Myeloma & Leukemia

High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism

(2012) Yuji Mishima et al.   INTERNATIONAL IMMUNOLOGY

Leveraging Administrative Data to Monitor Rituximab Use in 2875 Patients at 42 Freestanding Children's Hospitals across the United States

(2012) Marko Kavcic et al.   JOURNAL OF PEDIATRICS

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report

(2012) S Goldman et al.   LEUKEMIA

Rituximab for Children with Immune Thrombocytopenia: A Systematic Review

(2012) Yi Liang et al.   PLoS One

Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study

(2011) B. Rousseau et al.   ANNALS OF ONCOLOGY

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

(2011) O. E. Yri et al.   BLOOD

Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin's Lymphoma Patients Treated with Rituximab-Containing Regimens

(2011) D. Bedognetti et al.   JOURNAL OF IMMUNOLOGY

Possible misinterpretation of the mode of action of therapeutic antibodies in vitro: homotypic adhesion and flow cytometry result in artefactual direct cell death

(2010) J. Golay et al.   BLOOD

Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab

(2010) Toshiro Kurokawa et al.   HEMATOLOGICAL ONCOLOGY

Does rituximab increase the incidence of infectious complications? A narrative review

(2010) Theodoros Kelesidis et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia

(2010) Andrea Meinhardt et al.   JOURNAL OF CLINICAL ONCOLOGY

Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy

(2010) M. Tuccori et al.   ONCOLOGIST

Rituximab efficiency in children with steroid-dependent nephrotic syndrome

(2010) Anne-Laure Sellier-Leclerc et al.   PEDIATRIC NEPHROLOGY

Rituximab-Associated Infections

(2010) Juan C. Gea-Banacloche   SEMINARS IN HEMATOLOGY

Vaccinations in children with cancer

(2010) Susanna Esposito et al.   VACCINE

Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab

(2009) Marco Tuccori et al.   ANNALS OF HEMATOLOGY

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials

(2009) Liat Vidal et al.   JNCI-Journal of the National Cancer Institute

Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study

(2009) Heather E. Eve et al.   LEUKEMIA & LYMPHOMA

Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating

(2009) Kenneth R. Carson et al.   LEUKEMIA & LYMPHOMA

The late adverse events of rituximab therapy – rare but there!

(2009) Ron Ram et al.   LEUKEMIA & LYMPHOMA

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

(2009) Koichi Kamei et al.   PEDIATRIC NEPHROLOGY

A Randomized, Prospective Trial of Rituximab for Acute Rejection in Pediatric Renal Transplantation

(2008) V. Zarkhin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis

(2008) C. Stolz et al.   BLOOD

Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?

(2008) A Buser et al.   BONE MARROW TRANSPLANTATION

Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT

(2008) K Masjosthusmann et al.   BONE MARROW TRANSPLANTATION

Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma

(2008) L K Hicks et al.   BONE MARROW TRANSPLANTATION

The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence

(2008) Dina Attias et al.   CURRENT OPINION IN PEDIATRICS

Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature

(2008) Hiroki Yokoyama et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period

(2008) Seah H. Lim et al.   LEUKEMIA & LYMPHOMA

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: A report from the Children's Oncology Group

(2008) Timothy C. Griffin et al.   PEDIATRIC BLOOD & CANCER

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

(2007) Aarati Rao et al.   PEDIATRIC BLOOD & CANCER